Scientists pinpoint protein that could improve small cell lung cancer therapies
Approximately 15 percent of all lung cancers are small cell lung cancers, which grow rapidly and often develop resistance to chemotherapy. However, researchers at Virginia Commonwealth University Massey Cancer Center have revealed new insights into the mechanisms leading to this resistance that may lead to improved therapies.
Environmental exposures and cancer risk
Most people think of forests, parks or even city streets when they hear the word “environment,” but scientists define environment as everything outside the body that enters and interacts with the inside of the body. Some of these outside exposures have been linked to increased cancer risk.
New combination therapy developed for multiple myeloma
Each year, more than 25,000 Americans are diagnosed with multiple myeloma, a form of blood cancer that often develops resistance to therapies. However, researchers at Virginia Commonwealth University Massey Cancer Center are reporting promising results from laboratory experiments testing a new combination therapy that could potentially overcome the resistance hurdle.
And the award goes to…
Once again, numerous VCU Massey Cancer Center physicians were recognized as “Top Docs” in Richmond Magazine’s April 2014 issue. The list included 20 doctors from multiple specialties who provide care to Massey’s patients. The selections were the result of a survey that asked Richmond-area physicians who they would recommend in a range of specialties. The following Massey physicians were named as top performers in their respective categories.
Researchers uncover allergy-cancer connection
While many are stocking up on allergy medicine in preparation for spring, a new study from researchers at Virginia Commonwealth University Massey Cancer Center has uncovered a new connection between allergy and cancer that could potentially lead to therapies involving common antihistamines.